Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levosimendans Pharmacokinetics in Intensive Care Patients

NCT05076864 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05076864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05076864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levosimendans Pharmacokinetics in Intensive Care Patients
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 31, 2025
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, intensive care, metabolites, pharmacokinetics, renal failure